Skip to content
Our Approach
Our Approach
- Advanced Cell Engineering – Dual-targeted CAR constructs improve durability and reduce relapse.
- Scalable Manufacturing – A decentralized, near-patient production model minimizes delays and dramatically lowers costs.
- Global Accessibility – Our streamlined model allows treatment delivery in both leading academic hospitals and community healthcare centers.
- Expanding Indications – Beyond blood cancers, we are developing CAR-T therapies for autoimmune disorders, where T-cell redirection can restore immune balance without chronic immunosuppression.
